Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

Oncolytics Biotech® Inc. ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the expansion of its gastrointestinal ("GI") Tumor Scientific ...

Upon completion of both tranches, PharmaDrug will hold a 40% interest in Canurta, and Canurta limited partners will hold approximately 44% of PharmaDrug's issued and outstanding shares on a pro forma ...

Conditional market access schemes can accelerate access to effective new treatments. To better balance their costs and health benefits, collaborative negotiation is key in pricing.

China and India as Unequal Competitors China and India did not emerge as global economic powers through unrestricted exposure to international competition. Their industrial sectors benefited from ...

Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), presented their annual fund update at the NBDF Research Round Table in Washington, DC last month.

A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...

Partnership Supports Ainos' 2026 Strategic Focus on Advancing AI Nose Upstream and Accelerating Scent Data Accumulation in Advanced Wafer Fabs HOUSTON, TX / ACCESS Newswire / January 7, 2026 / Ainos, ...

In A Nutshell Korean researchers developed SC Fill paste, an injectable tissue filler made from processed human skin that ...

AbbVie on Wednesday denied it was in talks to buy Revolution Medicines after the Wall Street Journal reported the drugmaker ...

Royalty Pharma plc operates a diversified royalty portfolio while appearing in broader discussions tied to the nasdaq 100 ...

The British School in Colombo (BSC) hosted its Annual Christmas Carnival 2025, ‘Gingerbread Wonderland’, which was a huge ...